MENU
APVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aptevo Therapeutics (APVO) Ownership - Who owns Aptevo Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
40
Web
https://www.aptevotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.46M
P/E Ratio
N/A
Total Cash
663K
Projected Growth
N/A
Total Debt
5.21M
Revenue
N/A
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
APVO
Capitalization
4.46M
P/E Ratio
N/A
Risk (Beta)
1.34
Dividend Yield
N/A
Total Cash
663K
Total Cash/Share
0.04
Total Debt
5.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
6.1M
P/B Ratio
1.01
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
1.92
Current Revenue Per Employee
57666.67
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
32.06
Revenue To Assets
N/A
Shares Held By Institutions
612K
Shares Outstanding - Current
18.5M
Total Liabilities
11.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-96.974
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of immunology and cancer research services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
40
Web
https://www.aptevotherapeutics.com